by Andreas Kremer | May 12, 2022
Since its foundation in 2015, ITTM has been working very closely with numerous pharmaceutical companies in the context of IMI projects. To further strengthen these fruitful interactions ITTM is joining the Innovative Medicines for Luxembourg (IML) as a partner...
by Andreas Kremer | Apr 6, 2022
Recently an informative exchange between Bernhard Frühlinger (ADAM) and Andreas Kremer (ITTM) took place in Vienna regarding the importance as well as specifics of grants for startups and SMEs. The complete interview can be found here:...
by Andreas Kremer | Mar 29, 2022
SMEs are key players in the European pharmaceutical research and development landscape. In IHI projects, SMEs act as one key interface between the latest academic discoveries and implementation in industry. ITTM had the honour to contribut to a recent webinar around...
by Andreas Kremer | Mar 24, 2022
ITTM is specialised in data and knowledge management and the mission of ITTM is Making Data Actionable. Recently ITTM became member of the Powered by EBRC programme. Both organisations share the same culture and corporate values: Health-related data are very sensitive...
by Andreas Kremer | Feb 15, 2022
ITTM is participating in the COST action CA202117 Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer. It’s the first Mye-InfoBank hybrid workgroup meeting in Lisbon. It will be accompanied by the second MC meeting and the...
by Andreas Kremer | Jan 28, 2022
Job opportunities @ITTM: Scientific Data Curators and Scientific Programmers or Software Engineers. ITTM is a partner in the IMI OPTIMA project and we have open positions for scientific data curators and software engineers (programmers). This is an excellent...
